Alfred Merriweather joined Calypso Medical Technologies, Inc. in 2010 with more than 25 years of financial management experience including service as CFO in a number of medical technology and life science companies.

Prior to joining Calypso Medical, Mr. Merriweather served as Senior Vice President and Chief Financial Officer of Monogram Biosciences, a publicly held molecular diagnostics company with revenues of over $60 million derived from HIV and Oncology testing services. Mr. Merriweather has also served as Chief Financial Officer of Symphonix Devices, Inc., a publicly held manufacturer of implantable devices, Lipomatrix, Inc., a privately held medical device company, and Laserscope, a publicly held manufacturer of surgical laser systems. Prior to his experience in the life science industries, he spent six years with Price Waterhouse in London, England and San Jose, California.

Mr. Merriweather holds a bachelor of arts degree in economics from the University of Cambridge.